- Trials with a EudraCT protocol (455)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2,783)
455 result(s) found for: Bacteria.
Displaying page 1 of 23.
| EudraCT Number: 2005-004890-10 | Sponsor Protocol Number: KI DS 200509 | Start Date*: 2006-02-17 |
| Sponsor Name:Kvinnokliniken | ||
| Full Title: Vaginal colonization of the LN bacteria (patented human lactic acid producing bacteria) when conventional treatment of bacterial vaginosis and Candida vaginitis is followed by treatment with Vagipi... | ||
| Medical condition: Diagnosed Bacterial Vaginosis (BV) or Candida Vaginitis(CV) ICD: N76.8 (BV); N77.1*B37.3+(CV) | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-003048-11 | Sponsor Protocol Number: GIPIT002 | Start Date*: 2014-10-24 |
| Sponsor Name:GIPIT | ||
| Full Title: FEcal transplant, a Dazzling debut to Eradicate colonization with eXtreme drug resistant bacteria? | ||
| Medical condition: Patient harboring Extreme Drug Resistant (XDR) bacteria. Our trial try to eradicate this digestive tract colonization by performing a fecal transplantation. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-016566-82 | Sponsor Protocol Number: 05/SP/120 | Start Date*: 2009-12-29 |
| Sponsor Name:Belfast Health and Social Care Trust [...] | ||
| Full Title: Skin bacteria as a source of surgical infections: molecular epidemiology and prevention of wound contaimination | ||
| Medical condition: No medical condition under investigation, investigation of surgical wound contamination in spinal patients. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-005833-38 | Sponsor Protocol Number: LCR35_ESBL-01 | Start Date*: 2012-07-03 | |||||||||||
| Sponsor Name:Medical University of Vienna | |||||||||||||
| Full Title: Removal of intestinal colonization with multi resistant bacteria by ingestion of Lactobacillus casei rhamnosus LCR 35 | |||||||||||||
| Medical condition: Intestinal colonisation with multiresistant bacteria | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-023529-39 | Sponsor Protocol Number: RHM CHI 0548 | Start Date*: 2011-02-18 |
| Sponsor Name:Southampton University Hopsitals NHS Trust | ||
| Full Title: Reducing antibiotic tolerance using low dose nitric oxide in cystic fibrosis – a phase 2 pilot study | ||
| Medical condition: Cystic Fibrosis | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-010713-69 | Sponsor Protocol Number: LINPT01 | Start Date*: 2009-05-13 |
| Sponsor Name:Lek Pharmaceuticals d.d. | ||
| Full Title: Randomized, placebo controlled, double-blind, parallel group, multicentric Phase IV study on the clinical efficacy of lactic acid bacteria in form of hard capsules (capsule contains not less than 2... | ||
| Medical condition: Antibiotic associated diarrhea | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SI (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-023889-52 | Sponsor Protocol Number: AntiResDev-SWE | Start Date*: 2011-01-18 |
| Sponsor Name:Karolinska Universitetssjukhuset | ||
| Full Title: Effects of Clindamycin and Ciprofloxacin administration on the emergence, prevalence and persistence of antibiotic-resistant bacteria in humans | ||
| Medical condition: To assess the effect of ciprofloxacin and clindamycin administration on the proportions and types of cultivable antibiotic-resistant bacteria that emerge in the oropharynx, on the skin and in the... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-000244-10 | Sponsor Protocol Number: EGBAB | Start Date*: 2019-12-13 |
| Sponsor Name:Region Uppsala | ||
| Full Title: Influence of antibiotic treatment on the normal flora and the presence of resistance genes in known carriers of ESBL and VRE | ||
| Medical condition: Carriage of genes coding for vancomycin resistant enterococci (VRE) and extended spectrum betalactamase producing enterobacteriales (EPE) phenotypes. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-004634-26 | Sponsor Protocol Number: 4896 | Start Date*: 2015-05-20 | |||||||||||
| Sponsor Name:Royal Liverpool University Hospital [...] | |||||||||||||
| Full Title: The Effect of Live Attenuated Influenza Vaccine (LAIV) on Experimental Human Pneumococcal Colonisation (EHPC) Study | |||||||||||||
| Medical condition: Pneumococcal colonisation post inoculation | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-001774-24 | Sponsor Protocol Number: 3574 | Start Date*: 2006-09-13 |
| Sponsor Name:Newcastle u Tyne Hospitals NHS Trust | ||
| Full Title: INTESTINAL MICRO-ORGANISMS IN THE PATHOGENESIS OF NASH AND THE ROLE OF MODULATION OF ENTERIC BACTERIA IN TREATMENT. | ||
| Medical condition: Non alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-002343-99 | Sponsor Protocol Number: 1.0 | Start Date*: 2012-01-03 |
| Sponsor Name:Heart of England NHS Foundation Trust | ||
| Full Title: An Open-label Study into the Efficacy and Dosing of Probiotic Escherichia coli Nissle 1917 for Prevention of Gram-negative Gastric Colonisation in Ventilated Intensive Care Patients. | ||
| Medical condition: Gastric colonisation by pathogenic gram negative bacteria in ventilated adult ICU patients and it's prevention by the probiotic E.coli Nissle 1917 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-005738-12 | Sponsor Protocol Number: LIPSTIC.V.01 | Start Date*: 2013-03-27 |
| Sponsor Name:Alder Hey Children's NHS Foundation Trust | ||
| Full Title: Liverpool Pharmacokinetic/pharmacodynamics study of teicoplanin in children (LIPSTIC). | ||
| Medical condition: Gram-positive bacterial infection: late-onset neonatal sepsis, central line-associated blood stream infection, ventilator-associated pneumonia. | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-021879-85 | Sponsor Protocol Number: 10050 | Start Date*: 2010-09-08 |
| Sponsor Name:University of Nottingham | ||
| Full Title: Mode of action of Moviprep:impact on distribution of intestinal fluid and colonic microbiota | ||
| Medical condition: for bowel cleansing prior to any clinical procedure requiring a clean bowel, e.g, bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-002876-32 | Sponsor Protocol Number: AAD-CDD-001 | Start Date*: 2008-10-06 | |||||||||||
| Sponsor Name:University of Wales Swansea | |||||||||||||
| Full Title: A multicentre, randomised, placebo controlled trial of lactic acid bacteria in the prevention of antibiotic-associated diarrhoea (AAD) and Clostridium difficile diarrhoea (CDD) in patients aged 65 ... | |||||||||||||
| Medical condition: AAD is diarrhoea occurring in association with antibiotic treatment without an alternative cause. It occurs typically 2-8 weeks after exposure to antibiotics. The frequency of AAD varies markedly b... | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-009948-23 | Sponsor Protocol Number: H 552 000-0902 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Almirall Hermal GmbH | ||
| Full Title: A phase IIa single-center, randomized, controlled, observer-blind study to investigate the antimicrobial efficacy of topical formulations containing octenidine and prednicarbate in an "expanded flo... | ||
| Medical condition: Healthy volunteer trial to investigate whether topical formulations containing octenidine and octenidine plus prednicarbate exert an in vivo antibacterial action on skin surface bacteria multiplied... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-003362-26 | Sponsor Protocol Number: H552000-0809 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Almirall Hermal GmbH | ||
| Full Title: A phase IIa single-center, randomized, controlled, observer-blind study to investigate the antimicrobial efficacy of topical formulations containing octenidine and prednicarbate in an"expanded flor... | ||
| Medical condition: Healthy volunteer trial to investigate whether topical formulations containing Octenidine and Octenidine plus Prednicarbate exert an in vivo antibacterial action on skin surface bacteria multiplied... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-017823-24 | Sponsor Protocol Number: 1703 | Start Date*: 2010-03-19 |
| Sponsor Name:Tartu University Hospital | ||
| Full Title: Meropenem pharmacokinetics in very low birth weight neonates | ||
| Medical condition: proven or suspected sepsis, lower respiratory tract infection, complicated intraabdominal infection | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
| Trial protocol: EE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-005308-12 | Sponsor Protocol Number: 1111 | Start Date*: 2018-09-07 | |||||||||||
| Sponsor Name:Region Sjælland, Slagelse Hospital | |||||||||||||
| Full Title: Treatment of MRSA throat carriage with mupirocin irrigation | |||||||||||||
| Medical condition: Patientents being MRSA positive for a minimum of 6 months and concluded at least one konventional topical treatments unsuccessfully | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-003321-29 | Sponsor Protocol Number: 17-169 | Start Date*: Information not available in EudraCT |
| Sponsor Name:RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty | ||
| Full Title: Clinical relevance of the antimicrobial resistance testing in the treatment of chronic wounds with antiseptics | ||
| Medical condition: Decubitus, acute or chronic wounds (open wounds existing ≥ 14 days) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-002751-38 | Sponsor Protocol Number: PREPREP | Start Date*: 2021-02-01 |
| Sponsor Name:Region Östergötland | ||
| Full Title: Long-term effect of chlorhexidine gluconate 4% and Chlorhexidine alcohol 5 mg /ml on growth and recolonisation of bacteria on the skin | ||
| Medical condition: Cutaneous antibacterial efficacy in healthy volunteers. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
